{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:32:19Z","timestamp":1787841139579,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a leading cause of anovulatory infertility. Letrozole is the first-line agent for ovulation induction; however, response to the standard 5-day regimen may be suboptimal in some women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim is to compare the efficacy and safety of an extended 10-day letrozole regimen with the conventional 5-day regimen for ovulation induction in infertile women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>Prospective, open-label, parallel-group randomised controlled trial conducted at a tertiary care centre in North India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Eighty infertile women with PCOS (Rotterdam criteria, 2003) were randomised to receive either letrozole 2.5 mg daily for 10 days or 5 days. Up to three ovulation induction cycles were allowed. Follicular monitoring was performed using transvaginal ultrasonography. Ovulation was triggered with human chorionic gonadotropin, followed by timed intercourse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      Continuous variables were analysed using the\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test or Wilcoxon\u2013Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test. Categorical variables were compared using the Chi-square or Fisher\u2019s exact test. A\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The 10-day regimen showed a significantly higher follicular response in the first cycle compared to the 5-day regimen (85.0% vs. 52.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). Dose escalation and gonadotropin use were significantly lower in the extended regimen group. No cases of ovarian hyperstimulation syndrome were reported. Pregnancy rates were comparable between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The extended 10-day letrozole regimen significantly improves follicular response without increasing adverse outcomes and may improve cycle efficiency in women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_276_25","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:01:21Z","timestamp":1774634481000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of an Extended 10-day Letrozole Regimen Compared to the 5-day Regimen in Enhancing Ovulation in Infertile Women with Polycystic Ovary Syndrome: A Randomised Controlled Trial"],"prefix":"10.4103","volume":"19","author":[{"given":"Bhavneet","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology and AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology and AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"Mahey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology and AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroof Ahamad","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi K.","family":"Jayraj","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology and AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology and AIIMS, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"R1-20260330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R2-20260330","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R3-20260330","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20260330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"R5-20260330","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: Consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20260330","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.mcna.2008.04.008","article-title":"Basic infertility including polycystic ovary syndrome","volume":"92","author":"Brassard","year":"2008","journal-title":"Med Clin North Am"},{"key":"R7-20260330","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/GRF.0b013e3182353d0f","article-title":"Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome","volume":"54","author":"Casper","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"R8-20260330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"R9-20260330","first-page":"CD010287","article-title":"Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome","volume":"9","author":"Franik","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20260330","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/humupd\/dms003","article-title":"Aromatase inhibitors for PCOS: A systematic review and meta-analysis","volume":"18","author":"Misso","year":"2012","journal-title":"Hum Reprod Update"},{"key":"R11-20260330","first-page":"1","article-title":"Comparison of the effectiveness of 2.5mg versus 5mg doses of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome: A non-randomized control trial","volume":"12","author":"Irowa","year":"2023","journal-title":"J Womens Health Care"},{"key":"R12-20260330","doi-asserted-by":"crossref","first-page":"758508","DOI":"10.1155\/2012\/758508","article-title":"Dosage optimization for letrozole treatment in clomiphene-resistant patients with polycystic ovary syndrome: A prospective interventional study","volume":"2012","author":"Rahmani","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"R13-20260330","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00404-011-1951-5","article-title":"A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS","volume":"284","author":"Ramezanzadeh","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R14-20260330","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.21608\/ejhm.2019.28872","article-title":"Short letrozole therapy versus extended (long) letrozole therapy for induction of ovulation in women with polycystic ovary syndrome","volume":"74","author":"El-Aziz","year":"2019","journal-title":"Egypt J Hosp Med"},{"key":"R15-20260330","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s10815-020-01892-6","article-title":"A review of the physiology behind letrozole applications in infertility: Are current protocols optimal?","volume":"37","author":"Rose","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"R16-20260330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.fertnstert.2022.09.018","article-title":"Extending letrozole treatment duration is effective in inducing ovulation in women with polycystic ovary syndrome and letrozole resistance","volume":"119","author":"Zhu","year":"2023","journal-title":"Fertil Steril"},{"key":"R17-20260330","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.18203\/2320-1770.ijrcog20222786","article-title":"Low dose-extended letrozole versus double dose-short letrozole protocol for ovulation induction in polycystic ovary syndrome","volume":"11","author":"Jahan","year":"2022","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R18-20260330","first-page":"962","article-title":"Extended letrozole regimen for treatment of clomiphene resistant polycystic ovary syndrome patients","volume":"38","author":"Morad","year":"2021","journal-title":"Benha Med J"},{"key":"R20-20260330","first-page":"170","article-title":"A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome","volume":"5","author":"Mandelbaum","year":"2024","journal-title":"F S Rep"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_276_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:43:52Z","timestamp":1787838232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_276_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_276_25","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}